Mesoblast Limited
MESO
$14.53
-$0.10-0.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.08M | -20.08M | -27.10M | -27.10M | -23.97M |
| Total Depreciation and Amortization | 2.15M | 2.15M | 2.16M | 2.16M | 1.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.67M | 11.67M | 11.62M | 11.62M | 12.79M |
| Change in Net Operating Assets | -8.91M | -8.91M | -1.33M | -1.33M | -195.00K |
| Cash from Operations | -15.17M | -15.17M | -14.65M | -14.65M | -10.33M |
| Capital Expenditure | -211.00K | -211.00K | -287.00K | -287.00K | -53.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.50K | -92.50K | 33.50K | 33.50K | 366.50K |
| Cash from Investing | -303.50K | -303.50K | -253.50K | -253.50K | 313.50K |
| Total Debt Issued | 35.68M | 35.68M | -- | -- | -- |
| Total Debt Repaid | -35.24M | -35.24M | -3.09M | -3.09M | -1.79M |
| Issuance of Common Stock | 2.78M | 2.78M | 82.52M | 82.52M | 670.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.78M | -3.78M | -3.63M | -3.63M | -1.01M |
| Cash from Financing | -564.00K | -564.00K | 75.80M | 75.80M | -2.13M |
| Foreign Exchange rate Adjustments | 251.50K | 251.50K | 864.00K | 864.00K | -319.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.79M | -15.79M | 61.76M | 61.76M | -12.47M |